Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Supranuclear Palsy, Progressive 1Spinocerebellar Ataxias 1Spastic Paraplegia, Hereditary 1Obesity 1Neuromuscular Diseases 1Myotonic Dystrophy 1Myasthenia Gravis 1Muscular Dystrophy, Facioscapulohumeral 1Lambert-Eaton Myasthenic Syndrome 1Huntington Disease 1Charcot-Marie-Tooth Disease 1

Interventions

rozanolixizumab 8zilucoplan 7ravulizumab 6fludarabine 5efgartigimod alfa 5Cyclophosphamide 5telitacicept 3Prednisone 3inebilizumab 2Rituximab 2Pyridostigmine Bromide 2tofacitinib 1thymoglobulin 1talquetamab 1remibrutinib 1prednylidene 1iptacopan 1eculizumab 1deltacortene 1carmustine, poliferprosan 20 drug combination 1Walk Test 1Therapeutics 1Tacrolimus 1Steroids 1Robotic Surgical Procedures 1Psychodrama 1Prednisolone 1Plasma Exchange 1Peripheral Blood Stem Cell Transplantation 1Oxaloacetic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myasthenia Gravis × Walk Test × 1 year × Clear all
NCT07136844 2025-08-22

Acti-Adult

Centre Hospitalier Universitaire de Liege

Phase NA Recruiting
300 enrolled
Other

Charcot-Marie-Tooth Disease, Huntington Disease, Myasthenia Gravis, Myotonic Dystrophy, Neuromuscular Diseases, Obesity, Supranuclear Palsy, Progressive, Spastic Paraplegia, Hereditary, Lambert-Eaton Myasthenic Syndrome, Muscular Dystrophy, Facioscapulohumeral, Spinocerebellar Ataxias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡